Spyre Therapeutics Inc (SYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2006 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 2,656 | N/A |
| TOTAL | $2,730 | $N/A |
| Non-Current Assets | ||
| PPE Net | 162 | N/A |
| Other Non-Current Assets | 38 | 0 |
| TOTAL | $200 | $N/A |
| Total Assets | $2,930 | $N/A |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 345 | 0 |
| Accrued Expenses | 713 | N/A |
| TOTAL | $1,058 | $N/A |
| Non-Current Liabilities | ||
| TOTAL | $N/A | $N/A |
| Total Liabilities | $1,058 | $N/A |
| Shareholders' Equity | ||
| Common Shares | 811 | N/A |
| Retained earnings | -12,284 | N/A |
| Other shareholders' equity | 13,345 | 0 |
| TOTAL | $1,872 | $N/A |
| Total Liabilities And Equity | $2,930 | $0 |